AGEN Agenus Inc.

$4.35 +3.33%

2,245,955 Shares Traded
1,410,690 Average Volume (last 30 days)

as of February 16, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $1.27 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-22.88%
If Intiated One Month Ago, Shorts Have Realized a Return of:-11.54%
If Initiated Five Days ago, Shorts Have Realized a Return of:-14.78%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingShort Squeeze Either Occurring or Squeeze Potential Rising - Pay More Attention to Catalysts and Fundamentals
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 9.78%
Short Interest9.05 million
Float92.56 million
Short Ratio6.53
Market Cap$435.8 million
Market Maker ActivityDaily Short Volume

News

02-05-2018
Agenus gets modust bump from Bristol-Myers' success with Opdivo/Yervoy in first-line NSCLC, shares up 3% premarket (SeekingAlpha)
01-22-2018
Yet-to-be-released White House infrastructure plan published (SeekingAlpha)
01-22-2018
Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034) (PR Newswire)
01-22-2018
Agenus Inc. Closes $230 Million Royalty Monetization with HealthCare Royalty Partners (PR Newswire)
01-21-2018
Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge (SeekingAlpha)
01-09-2018
Your Daily Pharma Scoop: Ablynx Takeover Bid, Celgene Acquires Impact Biomedicines, Axovant Flops Again (SeekingAlpha)
01-08-2018
Premarket Gainers as of 9:05 am (SeekingAlpha)
01-08-2018
Agenus inks $230M royalty monetization deal; shares up 14% premarket (SeekingAlpha)
01-08-2018
Agenus Inc. Announces $230 Million Royalty Monetization with HealthCare Royalty Partners (PR Newswire)
01-04-2018
Agenus' Dr. John Castle Joins Thought Leadership Panel on I-O Combinations at 10th Annual Biotech Showcase 2018 (PR Newswire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 35.7%
Insider Percent7.6%

Earnings Stats

PE Ratio -3.72
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $3.89
50 Day Moving Average $3.7
52 Week High $5.45
52 Week Low $3.2



Data provided for free by IEX. Questions? Read the FAQ